NCT02842567View on ClinicalTrials.gov

Hydroxytyrosol and Vitamin E in Pediatric NASH

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
NAFLD
Interventions
DRUG

Hydroxytyrosol plus Vitamin E

This group will treated with 2 pills daily, each containing 3.75 mg of hydroxytyrosol plus 5 mg of Vitamin E, given orally for 16 weeks

DRUG

Placebo

This group will treated with 2 identical placebo pills daily given orally for 16 weeks.

Trial Locations (1)

00165

Hepatometabolic Department, Bambino Gesù Children's Hospital, Rome

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER

NCT02842567 - Hydroxytyrosol and Vitamin E in Pediatric NASH | Biotech Hunter | Biotech Hunter